The Global Health Impact Project

Progress Towards the Sustainable Development Goals

Fri, 05/10/2019 - 12:00pm
002 Robertson Hall
Event Category: 
Co-sponsored Event
Sponsored by the Liechtenstein Institute on Self-Determination at Princeton University

The Sustainable Development Goals aim to, “by 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases,” and ensure “access to safe, effective, quality and affordable essential medicines and vaccines for all” (SDG3). According to recent World Health Organization research, access to medicines and vaccinations in developing countries (SDG3b) remains low – global vaccination coverage stands at 85%, antiretroviral therapy only reaches half of those living with HIV, and progress to end malaria has stalled. Many countries in the Global South furthermore still lack the capacity for early warning, risk reduction, and management of national and global health risks (SDG3d).  The Global Health Impact (GHI) project seeks to constructively intervene in the policy debates around global health. The GHI project is a collaboration of researchers from civil society organizations and universities from around the world, committed to alleviating the global burden of disease. Under the direction of Prof. Nicole Hassoun (Binghamton University and Cornell University), they produce some of the most comprehensive models of essential medicines’ health consequences around the world to better advance access to treatment. The GHI index aims to measure the consequences of pharmaceutical products on global health, and estimates the disease impact in the absence of treatment using data on drug efficacy, disease incidence, and the global burden of disease remaining post-treatment. Ultimately, by illustrating this impact, the index can incentivize pharmaceutical companies and policy-makers to extend access to treatments in endemic regions. 


The index was first launched at the World Health Organization in Geneva in 2015. At the Princeton relaunch event, its new website and models will be introduced and two roundtable discussions will follow, linking the project to the Sustainable Development Goals.


12-1:30 Luncheon talk - Nicole Hassoun with Jacob Friedman and Aidan Hollis: Presentation of the GHI project and index

1:30-3:00 Roundtable - Achieving the Sustainable Development Goals: Self-Determination, Human Rights, Development, Policy, and Practice

3-3:30 Break

3:30-5 Roundtable - Beyond the Sustainable Development Goals: Data on Health to Promote Social Progress

Roundtable participants:

Jason F. Arnold, Senior Fellow and Assistant Director, Clinical and Translational Research Ethics, Institute of Human Values in Health Care, Medical University of South Carolina

Walden Bello, Former Member of the House of Representatives of the Philippines and Founder of Focus on the Global South

Barbara Buckinx, Associate Research Scholar, Liechtenstein Institute on Self-Determination, Woodrow Wilson School of Public and International Affairs, Princeton University

Marc Fleurbaey, Robert E. Kuenne Professor in Economics and Humanistic Studies, Professor of Public Affairs and the University Center for Human Values, Princeton University

Sakiko Fukuda-Parr, UN High-Level Panel on Access to Medicines, Professor of International Affairs at the New School, former Director and lead author of the UNDP Human Development Reports (1995-2004)

Leslie Gerwin, Associate Director, Program in Law and Public Affairs, Princeton University

Alexandra Greenberg, Global Executive Committee, Universities Allied for Essential Medicines

Nicole Hassoun, Founder of the Global Health Impact project, Professor of Philosophy, Binghamton University, and Visiting Scholar, Cornell University

Susan Hayes, Global Head, Corporate Responsibility, Novartis Oncology

Aidan Hollis, President and Director, Incentives for Global Health, Professor of Economics, University of Calgary

Suraj Madoori, US and Global Health Policy Director, Treatment Action Group

Jennifer Miller, Founder of the Good Pharma Scorecard, Assistant Professor, School of Medicine, Yale University

Sherif Mowafy, Branch Chief, Supply Chain for Health Division, Office of HIV/AIDS, USAID

Jerry Nutor, Postdoctoral Research Associate, Center for Health and Wellbeing, Woodrow Wilson School for Public and International Affairs, Princeton University

Olugbenga Ogedegbe, Professor of Population Health and Medicine, Chief of the Division of Health and Behavior, and Director of the Center for Healthful Behavior Change in the Department of Population Health, New York University Langone

Michael Palmedo, Assistant Director, Program on Information Justice and Intellectual Property, Washington College of Law, American University

Leonardo Palumbo, Advocacy Manager, Access to Medicines, Médecins Sans Frontières

Zain Rizvi, Law and Policy Researcher, Public Citizen

Rachel Taylor, Director, Corporate Responsibility, Merck

Sharyn Tenn, Senior Director, External Affairs and Product Access, International Partnership for Microbicides


Student team:

Olufisayo “Fisayo” Adeyina ’22, Princeton University

Matthew Altman ’21, Biology, English, and Philosophy, Binghamton University

Maria Camitan ’21, Integrative Neuroscience and Philosophy, Binghamton University

Kaitlyn Campbell ’19, Philosophy, Politics, and Law, Binghamton University

Jacob Friedman ’19, Business Analytics, Binghamton University

Morgan Steelman ’20, Woodrow Wilson School, Princeton University

Ashley Thomas ’20, Sociology and Art and Design, Binghamton University

Jacob West ’21, Statistics and Sociology, Binghamton University

Daiki Yoshioka ’19, Comparative Literature and Philosophy, Binghamton University

Co Sponsor(s): 
The Global Health Program, the Program in Law and Public Affairs, and Program in African Studies at Princeton University